P10 (PX)
(Delayed Data from NYSE)
$8.06 USD
-0.01 (-0.12%)
Updated Jun 13, 2024 04:00 PM ET
After-Market: $8.06 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth C Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$8.06 USD
-0.01 (-0.12%)
Updated Jun 13, 2024 04:00 PM ET
After-Market: $8.06 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth C Momentum C VGM
Zacks News
Material ETFs Gaining on Solid Q2 Earnings
by Sweta Killa
Given the upbeat results, material ETFs that have the top 10 holdings in these chemical titans performed well in the past 10 days.
Praxair (PX) Q1 Earnings & Revenues Top Estimates, Up Y/Y
by Zacks Equity Research
Praxair's (PX) 2018 performance will benefit from encouraging economic activity and strong backlog.
Praxair (PX) Beats Earnings and Revenues Estimates in Q2
by Zacks Equity Research
Praxair (PX) is expected to gain from positive economic activity and strong backlog.
What's in Store for Materials ETFs in Q2 Earnings?
by Sweta Killa
The strong expectation for Q2 earnings is boosting confidence in the sector. Here are popular materials ETFs to tap.
Chemical Stock Earnings Slated on Jul 26: APD, EMN & More
by Anindya Barman
Earnings momentum for the chemical industry is expected to continue in Q2 as the fundamental driving factors remain in place.
Praxair (PX) to Report Q2 Earnings: What's in the Offing?
by Zacks Equity Research
Improvement in industrial activities in the United States bodes well for Praxair (PX) in the second quarter. However, rising costs will constrain margins.
The Zacks Analyst Blog Highlights: Wells Fargo, IBM, Abbott, Texas Instruments and Praxair
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Wells Fargo, IBM, Abbott, Texas Instruments and Praxair
Top Stock Reports for Wells Fargo, IBM & Abbott
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Wells Fargo (WFC), IBM (IBM) and Abbott (ABT).
Should You Invest in the FID-MATRLS (FMAT)?
by Sweta Killa
Sector ETF report for FMAT
HUN or PX: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
HUN vs. PX: Which Stock Is the Better Value Option?
Company News For Jul 6, 2018
by Zacks Equity Research
Companies in the news are: BA,TSLA,PX,XPLR
Praxair Seals European Asset Sale Deal With Taiyo Nippon
by Zacks Equity Research
Praxair's (PX) agreement to divest majority of its European businesses to Taiyo Nippon Sanso drives a step toward Praxair-Linde merger.
APD or PX: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
APD vs. PX: Which Stock Is the Better Value Option?
Should You Invest in the Fidelity MSCI Materials Index ETF (FMAT)?
by Sweta Killa
Sector ETF report for FMAT
6 Dividend Aristocrats to Buy as Trump Irks G7
by Tirthankar Chakraborty
The resurgent stock market struggles for direction after Trump torpedoes G7's efforts to ease trade spat.
Praxair (PX) Worth Buying on Solidifying Product Demand
by Zacks Equity Research
Strengthening end markets, growing U.S. and global economy, and increasing applications of industrial gases are likely to boost demand for Praxair's (PX) products in the quarters ahead.
Why Is Praxair (PX) Up 1% Since Its Last Earnings Report?
by Zacks Equity Research
Praxair (PX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Should You Invest in the Fidelity MSCI Materials Index ETF (FMAT)?
by Zacks Equity Research
Sector ETF report for FMAT
Praxair (PX) Q1 Earnings Beat, Improve Y/Y on Solid Sales
by Zacks Equity Research
Praxair's (PX) first-quarter 2018 earnings gain from healthy trends in all end markets. Sales have grown in all segments, except for South America.
Praxair Inc. (PX) Tops Q1 Earnings and Revenues, View Solid
by Zacks Equity Research
Praxair Inc. (PX) reported impressive results for first-quarter 2018, with earnings and revenues surpassing their respective Zacks Consensus Estimate by 5.8% and 2.4%.
Should You Invest in the Fidelity MSCI Materials Index ETF (FMAT)?
by Zacks Equity Research
Sector ETF report for FMAT
Chemical Stock Earnings Slated on Apr 26: APD, EMN & More
by Zacks Equity Research
Earnings momentum for the chemical industry is expected to continue in Q1 as the fundamental driving factors remain in place.
Praxair (PX) to Report Q1 Earnings: What's in the Offing?
by Zacks Equity Research
Praxair's (PX) first-quarter 2018 earnings are to gain from solid U.S. industrial activities as well as strong demand in China. Seasonal weakness and lower Gulf Coast activities are to be a drag.
Praxair's Yara Freeport Contract to Boost Hydrogen Business
by Zacks Equity Research
Praxair's (PX) long-term supply agreement with Yara Freeport LLC is to solidify its businesses, especially of the hydrogen unit, in Texas.
Here's Why You Should Add Praxair (PX) to Your Portfolio
by Zacks Equity Research
Praxair (PX) stands to gain from a solid product portfolio and increasing applications of industrial gases. Returning value to shareholders is a priority.